[1]
“A comprehensive analysis of the risk variables linked to HIV infection”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 14, no. 1, pp. 89–94, Feb. 2025, doi: 10.61096/ijrpp.v14.iss1.2025.89-94.